Human Gene Therapy
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Genetics
Q1
└
Molecular Biology
Q2
└
Molecular Medicine
Q2
Publisher
SJR 2025
1.282
Q1
SJR Score
H-Index
167
Citations / Doc (2yr)
3.78
Total Docs. (latest)
103
Total Citations (3yr)
1,237
Publication type
Journals
ISSN
10430342, 15577422
Coverage
1990-2026
Journal Rank
#3,229
Subject Categories
Genetics
Q1
Molecular Biology
Q2
Molecular Medicine
Q2
Subject Areas
Aims & Scope
Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy.
The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.
Established in 1990, HGT provides a prestigious forum for publishing scientific and clinical research, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 103 |
| Total Docs. (3 years) | 341 |
| Total Refs. | 4,923 |
| Total Citations (3 years) | 1,237 |
| Citable Docs. (3 years) | 318 |
| Citations / Doc. (2 years) | 3.78 |
| Ref. / Doc. | 47.80 |
| % Female | 46.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.